Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
After an acute coronary syndrome, an adapted cardiac rehabilitation program is necessary to restore or increase physical capacities and decrease cardiovascular risk. This multidisciplinary care combines physical training sessions and therapeutic education workshops.
The COVID-19 pandemic imposed restrictions such as the closure of rehabilitation centres. To remedy this problem, one solution was to adapt the existing program to a remote cardiac telerehabilitation, i.e., medical and paramedical supervision of rehabilitation sessions and therapeutic patient education meetings via digital tools. Recent studies have shown that it was a safe (no reported adverse effects), effective (similar gains in peak oxygen consumption compared to traditional cardiac rehabilitation and patient-adherence alternative.
The hypothesis of this study is that telerehabilitation was more effective on cardiorespiratory functions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Home-based cardiac telerehabilitation (interventional group) | Patients followed the cardiac rehabilitation program at home. |
| |
| Traditional centre-based cardiac rehabilitation (control group) | Patients participates in the cardiac rehabilitation program in hospital. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| cardiac telerehabilitation program by videoconference | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline oxygen (VO2) (ml/min/kg) at the first ventilatory threshold (VT1) at 2 months | Variation of oxygen (VO2) (ml/min/kg) at the first ventilatory threshold (VT1) during a cardio-pulmonary exercise test (CPET) before and after 15 training sessions performed | Months: 0, 2 |
| Measure | Description | Time Frame |
|---|---|---|
| oxygen (VO2) peak | Variation of oxygen (VO2) peak before and after 15 training sessions performed | Months: 0, 2 |
| maximum power workload | Variation of maximum power workload before and after 15 training sessions performed |
Not provided
Inclusion Criteria:
Both groups:
For Telerehabilitation group:
Exclusion Criteria:
Both groups:
For Telerehabilitation group:
Not provided
Not provided
Not provided
Patient Acute Coronary Syndrome treated in the last 6 months will be included.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Hupin, MD | Centre Hospitalier Universitaire de Saint Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Saint-Etienne | Saint-Etienne | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Months: 0, 2 |
| power at the first ventilatory threshold (VT1) | Variation of power at the first ventilatory threshold (VT1) before and after 15 training sessions performed | Months: 0, 2 |
| maximum heart rate | Variation of maximum heart rate before and after 15 training sessions performed. | Months: 0, 2 |
| recovery heart rate | Variation of recovery heart rate before and after 15 training sessions performed. | Months: 0, 2 |
| obstructive ventilatory disorder | Variation of obstructive ventilatory disorder before and after 15 training sessions performed. | Months: 0, 2 |
| autonomic nervous system | Variation of autonomic nervous system before and after 15 training sessions performed. | Months: 0, 2 |
| muscular strength | Variation of muscular strength before and after 15 training sessions performed. | Months: 0, 2 |
| muscular endurance | Variation of muscular endurance before and after 15 training sessions performed. | Months: 0, 2 |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D054058 | Acute Coronary Syndrome |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D017202 | Myocardial Ischemia |
| D014652 | Vascular Diseases |
Not provided
Not provided